MedPath

Regular Physical Activity in Patients With Symptomatic Intracranial Arterial Stenosis

Phase 3
Recruiting
Conditions
Ischemic Stroke
Transient Ischemic Attack
Interventions
Behavioral: Regular physical activity
Other: Control group
Registration Number
NCT06615726
Lead Sponsor
Capital Medical University
Brief Summary

The objective of this study is to evaluate the effectiveness and safety of regular physical activity in preventing ischemic stroke events in patients with symptomatic intracranial arterial stenosis.

Detailed Description

The intracranial atherosclerotic stenosis (ICAS) is a common cause of ischemic stroke, and the result of increasing global burden of stroke. There are significant racial differences in the incidence of ICAS, which account for 8%-10% of stroke causes in North America and 30%-50% in Asia. In China, the incidence of ICAS in patients with ischemic stroke or transient ischemic attack (TIA) is as high as 46.6%. Previous studies have shown that stroke patients with ICAS have more severe symptoms, longer hospital stay and higher stroke recurrence rate, and the recurrence rate of stroke increases with the increase of stenosis degree. In the WASID (Warfarin-Aspirin Symptomatic Intracranial Disease trial and several prospective cohort studies) trial, the risk of recurrent stroke remained high even after aggressive medication and risk factor intervention in ICAS patients.

At present, the treatment of ICAS mainly includes drug therapy and endovascular therapy. Both the SAMMPRIS (Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis) trial in 2011 and the VISSIT (the Vitesse Intracranial Stent Study for Ischemic Stroke Therapy) trial in 2015, showed that aggressive medical treatment is more effective and safer than endovascular treatment . A 2018 review comparing stenting versus aggressive medical treatment for symptomatic ICAS also noted that medical treatment remains the preferred treatment for symptomatic ICAS patients compared to endovascular therapy. The results of the CASSISS trial in 2022, showed that endovascular therapy failed to show long-term benefit in severe patients with symptomatic ICAS. However, the above trials also found that even with aggressive medical treatment including dual antiplatelet therapy and intensive management of vascular risk factors, the one-year stroke recurrence rate in patients with symptomatic ICAS is still as high as 20%. This seriously endangers national lives and health, and restricts social and economic development. Therefore, there is an urgent need to explore new treatments to improve patient survival.

Several previous studies have shown that physical activity can reduce the incidence of all-cause stroke, cardiovascular disease and death, but little is known whether it can reduce the recurrence rate of stroke in patients with symptomatic ICAS. A subgroup analysis of the 2016 SAMMPPRIS trial found that in high-risk symptomatic ICAS patients, physical activity significantly reduced the likelihood of recurrent stroke, myocardial infarction, or vascular death. A 2023 cross-sectional study that included NOMAS (Northern Manhattan Study) data showed a strong negative association between physical activity and asymptomatic high-risk ICAS and was not regulated by vascular risk factors. Therefore, this trial conducts a multicenter, randomized, controlled, blinded trial of patients with symptomatic ICAS within 30 days to compare them with a control group that received only secondary stroke prevention health education to determine the association between regular physical activity and stroke recurrence rates within 1 year in patients with symptomatic ICAS.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1300
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
regular physical activity groupRegular physical activity-
Control groupControl group-
Primary Outcome Measures
NameTimeMethod
New ischemic stroke events1 year
Secondary Outcome Measures
NameTimeMethod
New ischemic stroke and transient ischemic attack events in the responsible vessel supply area1 year
New ischemic stroke and transient ischemic attack events1 year
Hemorrhagic stroke event1 year
Myocardial infarction1 year
The proportion of modified Rankin Scale score 0-1 (range, 0 to 6, with higher scores indicating greater disability)1 year
The score of min montreal cognitive assessment(range, 0 to 15, with higher scores indicating greater cognition)1 year
The score of Euro-QoL-5 Dimension(range, 0 to 100, with higher scores indicating better quality of life)1 year

Trial Locations

Locations (58)

Taihe Hospital of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Fuyang, Anhui, China

Huainan Sunshine Xinkang Hospital

πŸ‡¨πŸ‡³

Huainan, Anhui, China

Suzhou Municipal Hospital

πŸ‡¨πŸ‡³

Suzhou, Anhui, China

The Second People's Hospital of Wuhu

πŸ‡¨πŸ‡³

Wuhu, Anhui, China

Xuanwu Hospital, Capital Medical University

πŸ‡¨πŸ‡³

Beijing, Beijing, China

Beijing Pinggu District Hospital

πŸ‡¨πŸ‡³

Beijing, Beijing, China

Chongqing Sanbo Jiangling Hospital

πŸ‡¨πŸ‡³

Chongqing, Chongqing, China

Zhangzhou Hospital

πŸ‡¨πŸ‡³

Zhangzhou, Fujian, China

Foshan Fifth People's Hospital

πŸ‡¨πŸ‡³

Foshan, Guangdong, China

Foshan Nanhai District Sixth People's Hospital

πŸ‡¨πŸ‡³

Foshan, Guangdong, China

Brain Hospital Affiliated to Guangzhou Medical University

πŸ‡¨πŸ‡³

Guangzhou, Guangdong, China

Longchuan Hospital of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Heyuan, Guangdong, China

Hospital 925, Joint Logistics Support Force

πŸ‡¨πŸ‡³

Guizhou, Guiyang, China

Cangzhou People's Hospital of integrated Chinese and Western Medicine, Hebei Province

πŸ‡¨πŸ‡³

Cangzhou, Hebei, China

Army Military Medical University Officer School affiliated hospital

πŸ‡¨πŸ‡³

Shijiazhuang, Hebei, China

Tangshan Workers' Hospital

πŸ‡¨πŸ‡³

Tangshan, Hebei, China

Ningjin County Hospital

πŸ‡¨πŸ‡³

Xingtai, Hebei, China

Gongyi Xinhua Hospital of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Gongyi, Henan, China

Tongxu First Hospital

πŸ‡¨πŸ‡³

Kaifeng, Henan, China

Fangcheng County People's Hospital

πŸ‡¨πŸ‡³

Nanyang, Henan, China

Nanyang City Center Hospital

πŸ‡¨πŸ‡³

Nanyang, Henan, China

Shangqiu First People's Hospital

πŸ‡¨πŸ‡³

Shangqiu, Henan, China

Yongcheng Central Hospital

πŸ‡¨πŸ‡³

Shangqiu, Henan, China

The First Affiliated Hospital of Xinxiang Medical College

πŸ‡¨πŸ‡³

Xinxiang, Henan, China

The First Affiliated Hospital of Zhengzhou University

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Henan Provincial People's Hospital

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

The First Affiliated Hospital of Henan University of Chinese Medicine

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Zhengzhou First People's Hospital

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Zhengzhou Zhongkang Hospital

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Zhongmou County People's Hospital

πŸ‡¨πŸ‡³

Zhengzhou, Henan, China

Xihua County People's Hospital

πŸ‡¨πŸ‡³

Zhoukou, Henan, China

Lichuan Ethnic Chinese Medicine Hospital

πŸ‡¨πŸ‡³

Lichuan, Hubei, China

Hubei Third People's Hospital

πŸ‡¨πŸ‡³

Wuhan, Hubei, China

Yueyang City People's Court

πŸ‡¨πŸ‡³

Yueyang, Hubei, China

Liuyang City Jili Hospital

πŸ‡¨πŸ‡³

Liuyang, Hunan, China

Xiangtan Central Hospital

πŸ‡¨πŸ‡³

Xiangtan, Hunan, China

Jiujiang First People's Hospital

πŸ‡¨πŸ‡³

Jiujiang, Jiangxi, China

Jilin City People's Hospital

πŸ‡¨πŸ‡³

Jilin, Jilin, China

Xinmin People's Hospital

πŸ‡¨πŸ‡³

Shenyang, Liaoning, China

Affiliated Hospital of Inner Mongolia University for Nationalities

πŸ‡¨πŸ‡³

Tongliao, Neimenggu, China

Shandong University Qilu Hospital Dezhou Hospital

πŸ‡¨πŸ‡³

Dezhou, Shandong, China

Shengli Oilfield Central Hospital

πŸ‡¨πŸ‡³

Dongying, Shandong, China

Jinan High-tech East District Hospital

πŸ‡¨πŸ‡³

Jinan, Shandong, China

Laixi People's Hospital

πŸ‡¨πŸ‡³

Laixi, Shandong, China

Liaocheng People's Hospital

πŸ‡¨πŸ‡³

Liaocheng, Shandong, China

Lanshan District People's Hospital

πŸ‡¨πŸ‡³

Rizhao, Shandong, China

Affiliated Hospital of Shandong Second Medical University

πŸ‡¨πŸ‡³

Weifang, Shandong, China

Yantai Fushan District People's Hospital

πŸ‡¨πŸ‡³

Yantai, Shandong, China

Tengzhou Central Hospital

πŸ‡¨πŸ‡³

Zaozhuang, Shandong, China

Ningjin County People's Hospital

πŸ‡¨πŸ‡³

Dezhou, Shangdong, China

Shanghai Hechuan Rhein Hospital of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Shanghai, Shanghai, China

Yantai Yeda Hospital

πŸ‡¨πŸ‡³

Yantai, Shan, China

Sichuan Academy of Sciences Hospital

πŸ‡¨πŸ‡³

Chengdu, Sichuan, China

Jianyang City Hospital of Traditional Chinese Medicine

πŸ‡¨πŸ‡³

Jianyang, Sichuan, China

Ya 'an People's Hospital

πŸ‡¨πŸ‡³

Yaan, Sichuan, China

Shihezi People's Hospital

πŸ‡¨πŸ‡³

Shihezi, Xinjiang, China

Yongjia County People's Hospital

πŸ‡¨πŸ‡³

Wenzhou, Zhejiang, China

Yueqing People's Hospital

πŸ‡¨πŸ‡³

Wenzhou, Zhejiang, China

Β© Copyright 2025. All Rights Reserved by MedPath